Enriched with glutathione, it works to improve dullness, boost glow, and leave the skin looking healthier and more refreshed
for health monitoring, such as for pain management or medication compliance
Wegovy injection can be used for: Long-term weight loss and weight management in: adults and patients over 12 years old with obesity, or adults who are overweight and have a weight-related medical problem (e.g., blood pressure, type 2 diabetes, or high cholesterol) Reduce the risk of major cardiovascular events such as cardiovascular death, non-fatal myocardial infarction, or nonfatal stroke in: adults with established cardiovascular disease and either obesity or overweight
Opportunity Costs and Alternative Uses of Resources Responsible decision-making also considers opportunity costs - what alternative uses might the resources devoted to injectable glutathione serve
As of May 2026, FDA has also proposed excluding compounded semaglutide, tirzepatide, and liraglutide from the 503B Bulks List, with a public comment period closing June 29, 2026